Voyager Therapeutics Inc.
(VYGR) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Cash & Equivalents | 68.80M | 98.96M | 117.43M | 104.44M | 86.04M | 46.86M | 31.53M | 36.64M | 31.31M | 7.04M | 135.00K |
Short-Term Investments | 162.07M | 19.89M | 15.11M | 76.70M | 195.49M | 108.95M | 137.52M | 137.78M | 163.03M | n/a | n/a |
Long-Term Investments | 1.59M | 1.51M | 1.78M | 1.78M | 1.92M | 628.00K | 1.10M | 1.36M | 30.01M | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | 537.00K | 1.72M | 1.15M | 1.30M | 1.53M | 321.00K | 335.00K | 14.00K |
Receivables | 84.45M | 639.00K | 748.00K | 8.01M | 18.70M | 201.00K | n/a | 2.30M | 411.00K | n/a | n/a |
Inventory | n/a | 779.00K | 1.71M | 6.95M | 2.20M | 5.11M | 1.85M | 1.52M | -29.24M | n/a | n/a |
Other Current Assets | 4.35M | 5.01M | 3.41M | 6.85M | 4.15M | 6.47M | 3.50M | 2.06M | 1.15M | 1.32M | n/a |
Total Current Assets | 319.68M | 124.50M | 136.70M | 197.77M | 304.66M | 162.48M | 171.79M | 178.79M | 195.89M | 8.36M | 135.00K |
Property-Plant & Equipment | 30.00M | 33.34M | 55.38M | 61.50M | 46.46M | 12.77M | 10.28M | 7.89M | 3.23M | 2.80M | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 31.60M | 34.86M | 57.16M | 63.81M | 50.10M | 14.55M | 12.69M | 10.78M | 33.56M | 3.14M | 14.00K |
Total Assets | 351.28M | 159.36M | 193.85M | 261.58M | 354.76M | 177.03M | 184.48M | 189.57M | 229.46M | 11.50M | 149.00K |
Account Payables | 1.60M | 2.57M | 574.00K | 634.00K | 4.07M | 1.04M | 1.02M | 550.00K | 612.00K | 1.55M | 950.00K |
Deferred Revenue | 42.88M | 65.83M | 42.10M | 7.73M | 47.23M | 20.85M | 3.38M | 6.76M | 19.59M | n/a | n/a |
Short-Term Debt | 3.20M | 2.83M | 5.57M | 4.20M | 3.19M | n/a | n/a | n/a | n/a | n/a | 2.93M |
Other Current Liabilities | 16.82M | 7.82M | 10.95M | 14.21M | 21.52M | 9.79M | 11.50M | 6.49M | 3.73M | 920.00K | 105.00K |
Total Current Liabilities | 64.51M | 72.59M | 50.98M | 26.77M | 76.01M | 31.67M | 15.90M | 13.80M | 23.93M | 2.47M | 3.98M |
Long-Term Debt | 17.09M | 20.29M | 38.61M | 43.41M | 30.98M | n/a | n/a | n/a | n/a | 6.30M | n/a |
Other Long-Term Liabilities | 1.00M | 1.00M | 1.00M | 1.00M | 1.00M | 6.71M | 6.35M | 5.02M | 1.06M | 1.57M | n/a |
Total Long-Term Liabilities | 50.45M | 27.75M | 47.82M | 80.50M | 179.24M | 98.91M | 34.53M | 39.84M | 36.45M | 7.87M | 3.88M |
Total Liabilities | 114.96M | 100.34M | 98.80M | 107.26M | 255.25M | 130.58M | 50.43M | 53.64M | 60.38M | 10.35M | 3.98M |
Total Debt | 20.29M | 23.13M | 44.18M | 47.61M | 34.17M | n/a | n/a | n/a | n/a | 6.30M | 2.93M |
Common Stock | 44.00K | 38.00K | 38.00K | 37.00K | 37.00K | 32.00K | 32.00K | 26.00K | 25.00K | 1K | n/a |
Retained Earnings | -261.18M | -393.51M | -347.10M | -275.91M | -312.65M | -269.05M | -160.71M | -90.02M | -49.82M | -20.83M | -3.83M |
Comprehensive Income | -48.00K | -219.00K | -138.00K | -134.00K | -104.00K | -133.00K | -287.00K | -52.00K | -251.00K | -21.98M | n/a |
Shareholders Equity | 236.32M | 59.02M | 95.06M | 154.32M | 99.51M | 46.45M | 134.05M | 135.92M | 169.07M | 1.15M | -3.83M |
Total Investments | 163.67M | 19.89M | 15.11M | 76.70M | 197.41M | 109.58M | 138.62M | 139.14M | 193.04M | n/a | n/a |